Literature DB >> 7447705

Rimantadine hydrochloride blocks the second step of influenza virus uncoating.

A G Bukrinskaya, N K Vorkunova, R A Narmanbetova.   

Abstract

Two steps of influenza virus A/WSN uncoating in MDCK cells are described. The products of the first step are cores which accumulate in the nuclear-associated cytoplasm. The products of the second step are ribonucleoproteins which penetrate the nuclei. Rimantadine blocks the second step without interfering with the first one.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447705     DOI: 10.1007/bf01314742

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Cytoplasmic and nuclear input virus RNPs in influenza virus-infected cells.

Authors:  A G Bukrinskaya; G K Vorkunova; N K Vorkunova
Journal:  J Gen Virol       Date:  1979-12       Impact factor: 3.891

3.  Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein.

Authors:  M D Lubeck; J L Schulman; P Palese
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

4.  The matrix protein gene determines amantadine-sensitivity of influenza viruses.

Authors:  A J Hay; N C Kennedy; J J Skehel; G Appleyard
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

5.  On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride.

Authors:  J J Skehel; A J Hay; J A Armstrong
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

6.  Inhibition of influenza virus uncoating by rimantadine hydrochloride.

Authors:  W C Koff; V Knight
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

  6 in total
  7 in total

Review 1.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited.

Authors:  S J Armstrong; N J Dimmock
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

4.  Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 5.  Early interactions between animal viruses and the host cell: relevance to viral vaccines.

Authors:  S Patterson; J S Oxford
Journal:  Vaccine       Date:  1986-06       Impact factor: 3.641

Review 6.  Potential for the Repurposing of Adamantane Antivirals for COVID-19.

Authors:  Roger F Butterworth
Journal:  Drugs R D       Date:  2021-06-21

7.  Chapter 7 Orthomyxovirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.